Рет қаралды 20,379
The FDA just approved Vabysmo by Genentech for the treatment of Wet Macular Degeneration and Diabetic Macular Edema. What sets this drug apart from the rest is that it can lengthen the time between injections. From 4 to 8 weeks up to 16 weeks.
Retina Specialist, Dr. Joshua Mali was the first in the Sarasota area to inject a patient this week with this new medication for the treatment of Wet Macular Degeneration and Diabetic Macular Edema.